| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
33,342 |
27,193 |
$2.12M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
858 |
743 |
$51K |
| G0511 |
Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month |
1,865 |
1,765 |
$38K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,888 |
5,605 |
$28K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
418 |
327 |
$13K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,433 |
5,301 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
1,136 |
845 |
$368.41 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,494 |
1,452 |
$169.14 |
| 90688 |
|
77 |
40 |
$110.79 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,195 |
2,582 |
$41.73 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,113 |
2,567 |
$11.51 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,711 |
2,204 |
$2.90 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
678 |
570 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
473 |
351 |
$0.00 |
| 90686 |
|
15 |
13 |
$0.00 |
| 81000 |
|
844 |
662 |
$0.00 |
| 84703 |
|
106 |
81 |
$0.00 |
| 90733 |
|
14 |
14 |
$0.00 |
| 90619 |
|
60 |
51 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
55 |
38 |
$0.00 |
| 90656 |
|
13 |
13 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
585 |
491 |
$0.00 |
| 87420 |
|
76 |
63 |
$0.00 |
| 90715 |
|
70 |
61 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
180 |
152 |
$0.00 |
| 90649 |
|
89 |
78 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
300 |
267 |
$0.00 |
| 90633 |
|
22 |
17 |
$0.00 |